Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece. Vellopoulou K, Stefanou G, Tzanetakos C, Boubouchairopoulou N, et al. Eur J Gastroenterol Hepatol 2020 Sep 23. doi: 10.1097/MEG.0000000000001916.

Read + Share

Amedeo Smart

Independent Medical Education

Vellopoulou K, Stefanou G, Tzanetakos C, Boubouchairopoulou N, et al. Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece. Eur J Gastroenterol Hepatol 2020 Sep 23. doi: 10.1097/MEG.0000000000001916.
PMID: 32976189